Nanotechnology Now







Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Nanocopoeia Licenses New Polymer-Based Biomaterials Platform From the University of Western Ontario

Abstract:
Following the launch at BIO International in San Diego last week of NanoInterventions, their cardiovascular joint venture partnership, Nanocopoeia and WORLDiscoveries(TM) are pleased to announce their broader agreement to co-develop the biomedical uses of arborescent polyisobutylene-based block copolymers. Nanocopoeia, a drug delivery company specializing in therapeutic coatings for medical devices, will lead the development effort and WORLDiscoveries(TM) will participate as a partner in the market-targeted applications. The agreement includes an exclusive world-wide license, for all biomedical fields of use, for the polymer system that is the subject of US Patent No. 6,747,098 (2004) and nine other international issued patents.

Nanocopoeia Licenses New Polymer-Based Biomaterials Platform From the University of Western Ontario

ST. PAUL, MN and LONDON, ON, Canada | Posted on June 26th, 2008

Arborescent polyisobutylene-based block copolymers are branched polymers with unique properties for biomedical use. A major market opportunity is their use as a drug-eluting coating for medical devices such as coronary stents. When applied using Nanocopoeia's proprietary ElectroNanospray(TM) process, the polymer provides a highly controllable matrix for drug delivery and has excellent physical properties. For other applications, such as tissue implants, this family of polymers has many attributes in common with silicone materials but without the need of the additional chemicals that are required to formulate silicone-based devices.

Judit E. Puskas, PhD, P.Eng, led the team at Western that invented the family of polymers based on arborescent polyisobutylene. She held the Bayer/NSERC (Natural Science and Engineering Research Council of Canada) Industrial Research Chair at Western between 1998 and 2003, and is now Professor of Polymer Science at The University of Akron in Ohio. Dr. Puskas commented, "This polymer system has enormous flexibility in the way it can be applied, while remaining totally stable. That, together with the favorable biocompatibility profile of its building blocks, makes it an ideal interface with body tissues." Dr. Puskas will participate in the joint development program.

Nanocopoeia's drug delivery and coating technology uses the proprietary ElectroNanospray(TM) process to apply nanoparticle-based coatings. The unique process, which originated at the University of Minnesota, generates nanoparticles made of drugs and polymers and assembles them into films with controllable delivery.

The National Science Foundation's research funding has played an important role in launching the collaboration. The commercial development of Nanocopoeia's ElectroNanospray(TM) technology for biomedical applications has been supported through multiple SBIR Phase II and supplemental awards from the NSF Division of Industrial Innovation and Partnerships. In the course of that research, the Company's search for novel coating polymer systems led them to Dr. Puskas, resulting in the ongoing productive collaboration. Dr. Puskas' research is supported by the NSF Division of Materials Research.

Nanocopoeia's CEO, Robert A. Hoerr, MD, PhD, said, "Based on our success in working with this polymer system, we believe it will have applicability for a broad range of biomedical uses." He further commented that a first use of the polymer has been as a prototype drug-eluting stent coating based on arborescent polyisobutylene-block-polystyrene (abbreviated arbIBS) used by the joint venture NanoInterventions for its Mouse Stent Model. He continued, "Given the strong interest that NanoInterventions' Mouse Stent Model generated at BIO, we believe the polymer will be a key element in helping us to define next generation of stent-delivered therapies."

NanoInterventions is a joint venture partnership that is launching the first rapid screening model for new coronary stent coatings, using a genetically modified mouse strain with human-like atherosclerosis, a mini- stent, and experimental coatings on the stent. Joint venture partners other than Nanocopoeia and Western include Stentome, LLC, an interventional cardiology company based in Palo Alto, CA, Oxford, UK, and Galway, Ireland, and The Integra Group, a medical research organization based in Brooklyn Park, MN, that provides a full range of preclinical and clinical development services. NanoInterventions was a featured company in the Positively Minnesota pavilion in the BIO International exhibition hall, from June 17-20, 2008.

With annual research expenditures of more than $223 million and an international reputation for success, The University of Western Ontario ranks as one of the top ten research-intensive universities in Canada. Offering Canada's best student experience among its peers, Western and its affiliated research institutes provide a culture that encourages entrepreneurial research and innovation.

WORLDiscoveries(TM) is a joint venture between Lawson Health Research Institute and The University of Western Ontario, including Robarts Research Institute, that capitalizes on the institutions' combined research strengths related to medical and health-related sciences, energy and the environment and new materials. The London region is recognized as a national leader in these key areas, and the city has identified them as opportunities for further growth.

Rob Herold, Associate Director of Western's Industrial Liaison Office, commented, "The innovative structure of our licensing partnership with Nanocopoeia lets us participate in the evolving healthcare applications of this polymer platform. WORLDiscoveries(TM) was structured to enable us work with highly entrepreneurial companies like Nanocopoeia and share in their upside potential, in addition to the standard licensing process that we have traditionally used. We have great confidence both in the technology and in our new partner."

####

For more information, please click here

Copyright © PR Newswire Association LLC.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Rutgers, NIST physicists report technology with potential for sub-micron optical switches March 31st, 2015

Prototype 'nanoneedles' generate new blood vessels in mice: Scientists have developed tiny 'nanoneedles' that have successfully prompted parts of the body to generate new blood vessels, in a trial in mice March 31st, 2015

Super sensitive measurement of magnetic fields March 31st, 2015

Nanomedicine pioneer Mauro Ferrari at ETH Zurich March 31st, 2015

Academic/Education

SUNY Poly CNSE and Title Sponsor SEFCU Name Capital Region Teams Advancing to the Final Round of the 2015 New York Business Plan Competition March 30th, 2015

LAMDAMAP 2015 hosted by the University March 26th, 2015

SUNY Poly & M+W Make Major Announcement: Major Expansion To Include M+W Owned Gehrlicher Solar America Corporation That Will Create up to 400 Jobs to Develop Solar Power Plants at SUNY Poly Sites Across New York State March 26th, 2015

SUNY POLY CNSE to Host First Ever Northeast Semi Supply Conference (NESCO) Conference Will Connect New and Emerging Innovators in the Northeastern US and Canada with Industry Leaders and Strategic Investors to Discuss Future Growth Opportunities in NYS March 25th, 2015

Nanomedicine

Nanion Technologies Appoints James Costantin as Director of Customer Relations: Nanion is pleased to announce the appointment of Dr. James Costantin as Director of Customer Relations at Nanion Technologies Inc. March 31st, 2015

Nanomedicine shines light on combined force of nanomedicine and regenerative medicine March 31st, 2015

Prototype 'nanoneedles' generate new blood vessels in mice: Scientists have developed tiny 'nanoneedles' that have successfully prompted parts of the body to generate new blood vessels, in a trial in mice March 31st, 2015

Nanomedicine pioneer Mauro Ferrari at ETH Zurich March 31st, 2015

Materials/Metamaterials

Wrapping carbon nanotubes in polymers enhances their performance: Scientists at Japan's Kyushu University say polymer-wrapped carbon nanotubes hold much promise in biotechnology and energy applications March 30th, 2015

DFG to Establish One Clinical Research Unit and Five Research Units: New Projects to Investigate Complications in Pregnancy, Particle Physics, Nanoparticles, Implants and Transport Planning / Approximately 13 Million Euros in Funding for an Initial Three-Year Period March 28th, 2015

Chemists make new silicon-based nanomaterials March 27th, 2015

UT Dallas engineers twist nanofibers to create structures tougher than bulletproof vests March 27th, 2015

Announcements

Rutgers, NIST physicists report technology with potential for sub-micron optical switches March 31st, 2015

Prototype 'nanoneedles' generate new blood vessels in mice: Scientists have developed tiny 'nanoneedles' that have successfully prompted parts of the body to generate new blood vessels, in a trial in mice March 31st, 2015

Super sensitive measurement of magnetic fields March 31st, 2015

Nanomedicine pioneer Mauro Ferrari at ETH Zurich March 31st, 2015

Patents/IP/Tech Transfer/Licensing

From tobacco to cyberwood March 31st, 2015

Roll up your screen and stow it away? Tel Aviv University researchers develop molecular backbone of super-slim, bendable digital displays March 30th, 2015

Novel nanoparticle therapy promotes wound healing March 27th, 2015

New processing technology converts packing peanuts to battery components March 22nd, 2015

Nanobiotechnology

From tobacco to cyberwood March 31st, 2015

Wrapping carbon nanotubes in polymers enhances their performance: Scientists at Japan's Kyushu University say polymer-wrapped carbon nanotubes hold much promise in biotechnology and energy applications March 30th, 2015

'Atomic chicken-wire' is key to faster DNA sequencing March 30th, 2015

Designer's toolkit for dynamic DNA nanomachines: Arm-waving nanorobot signals new flexibility in DNA origami March 27th, 2015

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More










ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2015 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE